Pulmonary sarcoidosis;Pulmonale sarkoidose

Pneumologie

Volumn 59, Issue 6, 2005, Pages 378-394

  Kirsten, D ^a   Costabel, U ^b  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

^b RUHRLANDKLINIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ACUTE DISEASE; CHRONIC DISEASE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SARCOIDOSIS;

HUMANS; SARCOIDOSIS, PULMONARY;

EID: 23344453956     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870910     Document Type: Review

References (29)

1. Scharkoff T. Epidemiologie der Sarkoidose. Pneumologie 1993; 47: 588-592
2. Kirsten D. Sarkoidose in Deutschland. Pneumologie 1995; 48: 378-382
3. Hunninghake GW, Costabel U, Ando M et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-173
4. Drent M, Wirnsberger RM, Vries J de et al. Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J 1999; 13: 718-722
5. Deutsche Gesellschaft für Pneumologie. Empfehlungen zur Therapie der Sarkoidose. Pneumologie 1998; 52: 26-30
6. DeRemee RA. The roentgenolographic staging of sarcoidosis-historic and contemporary perspectices. Chest 1983; 83: 128-133
7. Wurm K. Stadiengesetzlichkeit und Thoraxröntgenologie. In: Wurm K (Hrsg.). Sarkoidose. Stuttgart, New York: Thieme Verlag, 1983: 75-105
8. Winterbauer RH, Hutchinson JF. Use of pulmonary function tests in the management of sarcoidosis. Chest 1980; 78: 640-647
9. Costabel U. Sarcoidosis: clinical update. Eur Respir J 2001; 18 (Suppl. 32): 56s-68s
10. Schulte W, Costabel U, Kirsten D. Kardiale Sarkoidose. Pneumologie 2003; 57: 752-760
11. Chapman JT, Mehta AC. Bronchoscopy in sarcoidosis: diagnostic an therapeutic interventions. Curr Opin Pulm Med 2003; 9: 402-407
12. Costabel U. Atlas der bronchoalveolären Lavage. Stuttgart: Thieme Verlag, 1994
13. Remy-Jardin M, Giraud F, Remy J et al. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 1994; 191: 675-680
14. Costabel U, Bois R du, Eklund A et al. Concensus Conference: Activity of Sarcoidosis. Eur Respir J 1994; 7: 624-627
15. Sharma P, Smith I, Maguire G et al. Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet 1997; 349: 1602-1603
16. Müller-Quernheim J. Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 22-37
17. Hillerdal G, Nou E, Ostermann K et al. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984; 130: 29-32
18. Viskum K, Vestbo J. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 1993; 6: 349-353
19. Paramothayan S, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA 2002; 287: 1301-1307
20. Gibson GJ, Prescott RJ, Muers MF et al. British Thoracic Sarcoidosis Study: effects on long-term corticosteroid treatment. Thorax 1996; 51: 238-247
21. Hunninghake GW, Gilbert S, Pueringer R et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994; 149: 893-898
22. Gottlieb JE, Israel HL, Steiner RM et al. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997; 111: 623-631
23. Müller-Quernheim J, Kienast K, Held M et al. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respr J 1999; 14: 1117-1122
24. Baughman RP, Lower E. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 1990; 142: 1268-1271
25. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999; 54: 742-746
26. Baltzan M, Mehta S, Kirham TH et al. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 1999; 160: 192-197
27. Sharma OP. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurologic involvement. Arch Neurol 1998; 55: 1248-1254
28. Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 70-74
29. Zabel P, Entzian P, Dahlhoff K et al. Pentoxifylline in the treatment of sarcoidosis. Am J Respir Crit Care Med 1997; 155: 1665-1669